Hainan Shuangcheng Pharmaceuticals Co., Ltd. (SHE:002693)
China · Delayed Price · Currency is CNY 8.20
-0.10 (-1.20%)
Aug 22, 2025, 2:45 PM CST
SHE:002693 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -79.83 | -78.3 | -50.74 | 9.01 | -20.33 | -53.33 | Upgrade |
Depreciation & Amortization | 54.14 | 52.34 | 52.67 | 57.54 | 54.33 | 57.09 | Upgrade |
Other Amortization | 3.23 | 3.12 | 1.37 | 0.98 | 1.16 | 1.2 | Upgrade |
Loss (Gain) From Sale of Assets | 0.13 | 0.02 | -0.47 | -29.91 | -13.79 | 1.21 | Upgrade |
Asset Writedown & Restructuring Costs | 19.01 | 19.01 | 0.12 | 2.12 | 0.05 | 9.95 | Upgrade |
Loss (Gain) From Sale of Investments | 9.37 | 9.4 | 37.1 | -4.63 | -4.12 | -2.85 | Upgrade |
Provision & Write-off of Bad Debts | -0.08 | 0.18 | 1.15 | -0.09 | -0.05 | 0.36 | Upgrade |
Other Operating Activities | -15.23 | -18.42 | -8.29 | -5.27 | -8.61 | -11.99 | Upgrade |
Change in Accounts Receivable | 8.49 | -3.48 | 4.99 | -13.83 | 5.39 | 39.81 | Upgrade |
Change in Inventory | -32.02 | -19.76 | -12.45 | -9.89 | -4.77 | -4.27 | Upgrade |
Change in Accounts Payable | 14.35 | -5.02 | -9.66 | 19.57 | 13.83 | -48.86 | Upgrade |
Change in Other Net Operating Assets | - | - | -3.17 | - | - | - | Upgrade |
Operating Cash Flow | -18.91 | -40.83 | 11.64 | 25.22 | 23.55 | -10.5 | Upgrade |
Operating Cash Flow Growth | - | - | -53.84% | 7.07% | - | - | Upgrade |
Capital Expenditures | -22.02 | -24.91 | -49.2 | -32.98 | -31.64 | -51.57 | Upgrade |
Sale of Property, Plant & Equipment | 1.49 | 0.78 | 9.83 | 26.98 | 21.67 | 1.99 | Upgrade |
Investment in Securities | 10.93 | 28.48 | 61.03 | -83.76 | 38.85 | -24.75 | Upgrade |
Other Investing Activities | 0.47 | 0.69 | 2.75 | 4.69 | 4.12 | 2.85 | Upgrade |
Investing Cash Flow | -9.13 | 5.04 | 24.42 | -85.07 | 32.99 | -71.48 | Upgrade |
Short-Term Debt Issued | - | 22.45 | 22.94 | 7.61 | - | - | Upgrade |
Long-Term Debt Issued | - | 80 | - | 50 | - | 56.97 | Upgrade |
Total Debt Issued | 49.28 | 102.45 | 22.94 | 57.61 | - | 56.97 | Upgrade |
Short-Term Debt Repaid | - | -1.83 | -1.15 | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -12.5 | -60 | -12 | -55.34 | -1.82 | Upgrade |
Total Debt Repaid | -23.33 | -14.33 | -61.15 | -12 | -55.34 | -1.82 | Upgrade |
Net Debt Issued (Repaid) | 25.95 | 88.12 | -38.2 | 45.61 | -55.34 | 55.15 | Upgrade |
Issuance of Common Stock | 0.01 | 0.42 | 7.42 | 10.45 | 13.37 | - | Upgrade |
Common Dividends Paid | -7.58 | -7.19 | -8.69 | -11.13 | -9.1 | -9.76 | Upgrade |
Other Financing Activities | -4.01 | -4.01 | - | - | 10.45 | - | Upgrade |
Financing Cash Flow | 14.36 | 77.34 | -39.47 | 44.93 | -40.62 | 45.39 | Upgrade |
Foreign Exchange Rate Adjustments | 0.37 | 0.17 | -0 | 0.1 | -0.11 | -0.29 | Upgrade |
Net Cash Flow | -13.32 | 41.72 | -3.41 | -14.82 | 15.82 | -36.88 | Upgrade |
Free Cash Flow | -40.93 | -65.73 | -37.56 | -7.77 | -8.09 | -62.07 | Upgrade |
Free Cash Flow Margin | -25.05% | -37.73% | -15.92% | -2.83% | -2.52% | -23.04% | Upgrade |
Free Cash Flow Per Share | -0.10 | -0.16 | -0.09 | -0.02 | -0.02 | -0.15 | Upgrade |
Cash Income Tax Paid | 11.59 | 14.84 | 31.92 | 18.04 | 31.61 | 33.14 | Upgrade |
Levered Free Cash Flow | -2.94 | -31.22 | -31.8 | -23.48 | 27.13 | -24.37 | Upgrade |
Unlevered Free Cash Flow | 3.22 | -25.45 | -25.81 | -16.49 | 32.78 | -18.12 | Upgrade |
Change in Working Capital | -9.65 | -28.16 | -21.27 | -4.53 | 14.9 | -12.15 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.